For the long-term symptomatic treatment of persistent, moderate to severe asthma in patients requiring regular bronchodilator therapy in combination with long-term anti-inflammatory therapy (inhaled and / or oral glucocorticoids). Glucocorticoid therapy should be continued on a regular basis. Atimos is indicated for the relief of broncho-obstructive symptoms in patients with chronic obstructive pulmonary disease (COPD).
Clenil Modulite is indicated for the prophylactic management of mild, moderate, or severe asthma in adults or children: Mild asthma : Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular basis Moderate asthma : Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone Severe asthma : Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms